What You Ought to Know:
– GHX, a healthcare provide chain chief introduced it has entered right into a definitive settlement to obtain a strategic funding from personal fairness agency Warburg Pincus. As a part of this transaction, minority investor Thoma Bravo has exited its funding. Present investor Temasek, an funding firm headquartered in Singapore, will stay the bulk fairness holder.
– GHX has workers in the USA, Canada and Europe and is thought for working the most important healthcare buying and selling community representing greater than 80% of licensed beds within the U.S. and greater than 85% of med-surg merchandise stream by way of the platform. Following its acquisition of Lumere in 2020, GHX additionally operates the most important unified knowledge core of merchandise, vendor, transaction knowledge and scientific proof. The corporate’s experience in knowledge and analytics helps provide chain, scientific and monetary groups all over the world make extra knowledgeable selections.
– The phrases of the transaction weren’t disclosed. J.P. Morgan Securities LLC acted as unique monetary advisor to GHX, and Cleary Gottlieb Steen & Hamilton LLP acted as authorized advisor to GHX.